Herpes simplex virus 1 infection activates poly(ADP-ribose) polymerase and triggers the degradation of poly(ADP-ribose) glycohydrolase

Journal of Virology

Volumn 86, Issue 15, 2012, Pages 8259-8268

  Grady, Sarah L ^a   Hwang, Jesse ^a   Vastag, Livia ^a,b   Rabinowitz, Joshua D ^a   Shenk, Thomas ^a  

^a PRINCETON UNIVERSITY   (United States)

^b Castleton State College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; CASPASE; GLYCOSIDASE; ISOENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 2; POLY(ADENOSINE DIPHOSPHATE RIBOSYL)GLYCOHYDROLASE; PROTEASOME; PROTEIN ICP 0; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL METABOLISM; CONTROLLED STUDY; DNA DAMAGE; DNA REPLICATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME METABOLISM; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS REPLICATION;

CELLS, CULTURED; DNA REPLICATION; DNA, VIRAL; GLYCOSIDE HYDROLASES; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; NAD; POLY(ADP-RIBOSE) POLYMERASES; PROTEOLYSIS; UBIQUITIN-PROTEIN LIGASES;

HUMAN HERPESVIRUS 1;

EID: 84864381495     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00495-12     Document Type: Article

References (50)

1. Andrabi SA, et al. 2006. Poly(ADP-ribose) (PAR) polymer is a death signal. Proc. Natl. Acad. Sci. U. S. A. 103:18308-18313.
2. Blaho JA, et al. 1992. Differences in the poly(ADP-ribosyl)ation patterns of ICP4, the herpes simplex virus major regulatory protein, in infected cells and in isolated nuclei. J. Virol. 66:6398-6407.
3. Blenn C, Wyrsch P, Althaus FR. 2011. The ups and downs of tannins as inhibitors of poly(ADP-Ribose)glycohydrolase. Molecules 16:1854-1877.
4. Browne E, Wing B, Coleman D, Shenk T. 2001. Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. J. Virol. 75:12319-12330.
5. Burns DM, Ying W, Kauppinen TM, Zhu K, Swanson RA. 2009. Selective down-regulation of nuclear poly(ADP-ribose) glycohydrolase. PLoS One 4:e4896. doi:10.1371/journal.pone.0004896.
6. D'Amours D, Desnoyers S, D'Silva I, Poirier GG. 1999. Poly(ADPribosyl) ation reactions in the regulation of nuclear functions. Biochem. J. 342:249-268.
7. Davidovic L, Vodenicharov M, Affar EB, Poirier GG. 2001. Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism. Exp. Cell Res. 268:7-13.
8. Delgado T, et al. 2010. Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 107:10696-10701.
9. Ejercito PM, Kieff ED, Roizman B. 1968. Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J. Gen. Virol. 2:357-364.
10. Elion GB. 1982. Mechanism of action and selectivity of acyclovir. Am. J. Med. 73:7-13.
11. Giuliano M, D'Anneo A, De Blasio A, Vento R, Tesoriere G. 2003. Apoptosis meets proteasome, an invaluable therapeutic target of anticancer drugs. Ital. J. Biochem. 52:112-121.
12. Ha HC, et al. 2001. Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration. Proc. Natl. Acad. Sci. U. S. A. 98:3364-3368.
13. Hagglund R, Roizman B. 2003. Herpes simplex virus 1 mutant in which the ICP0 HUL-1 E3 ubiquitin ligase site is disrupted stabilizes cdc34 but degrades D-type cyclins and exhibits diminished neurotoxicity. J. Virol. 77:13194-13202.
14. Haince JF, Ouellet ME, McDonald D, Hendzel MJ, Poirier GG. 2006. Dynamic relocation of poly(ADP-ribose) glycohydrolase isoforms during radiation-induced DNA damage. Biochim. Biophys. Acta 1763:226-237.
15. Hasmann M, Schemainda I. 2003. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res. 63: 7436-7442.
16. Honess RW, Watson DH. 1977. Herpes simplex virus resistance and sensitivity to phosphonoacetic acid. J. Virol. 21:584-600.
17. Huber A, Bai P, de Murcia JM, de Murcia G. 2004. PARP-1, PARP-2 and ATM in the DNA damage response: functional synergy in mouse development. DNA Repair (Amst.) 3:1103-1108.
18. Koh DW, et al. 2004. Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality. Proc. Natl. Acad. Sci. U. S. A. 101:17699-17704.
19. Krishnakumar R, Kraus WL. 2010. The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol. Cell 39:8-24.
20. Li Z, et al. 2012. Herpes simplex virus requires PARP activity for efficient replication and induces ERK-dependent phosphorylation and ICP0-dependent nuclear localization of tankyrase 1. J. Virol. 86:492-503.
21. Lin SJ, Guarente L. 2003. Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease. Curr. Opin. Cell Biol. 15:241-246.
22. 4 zinc ring finger reveals a requirement for ICP0 in the expression of the essential α27 gene. J. Virol. 71:8602-8614.
23. Loh VM, Jr, et al. 2005. Phthalazinones. Part 1: the design and synthesis of a novel series of potent inhibitors of poly(ADP-ribose)polymerase. Bioorg. Med. Chem. Lett. 15:2235-2238.
24. Lu W, et al. 2010. Metabolomic analysis via reversed-phase ion-pairing liquid chromatography coupled to a stand alone Orbitrap mass spectrometer. Anal. Chem. 82:3212-3221.
25. Malanga M, Pleschke JM, Kleczkowska HE, Althaus FR. 1998. Poly-(ADP-ribose) binds to specific domains of p53 and alters its DNA binding functions. J. Biol. Chem. 273:11839-11843.
26. Mattiussi S, et al. 2007. Inhibition of Poly(ADP-ribose)polymerase impairs Epstein Barr virus lytic cycle progression. Infect. Agents Cancer 2:18. doi:10.1186/1750-9378-2-18.
27. Melamud E, Vastag L, Rabinowitz JD. 2010. Metabolomic analysis and visualization engine for LC-MS data. Anal. Chem. 82:9818-9826.
28. Menear KA, et al. 2008. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phth alazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J. Med. Chem. 51:6581-6591.
29. Meyer-Ficca ML, Meyer RG, Coyle DL, Jacobson EL, Jacobson MK. 2004. Human poly(ADP-ribose) glycohydrolase is expressed in alternative splice variants yielding isoforms that localize to different cell compartments. Exp. Cell Res. 297:521-532.
30. Mortusewicz O, Fouquerel E, Ame JC, Leonhardt H, Schreiber V. 2011. PARG is recruited to DNA damage sites through poly(ADP-ribose)- and PCNA-dependent mechanisms. Nucleic Acids Res. 39:5045-5056.
31. Munger J, Bajad SU, Coller HA, Shenk T, Rabinowitz JD. 2006. Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog. 2:e132. doi:10.1371/journal.ppat.0020132.
32. Munger J, et al. 2008. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat. Biotechnol. 26: 1179-1186.
33. Ohashi Y, et al. 1986. Poly(ADP-ribosyl)ation of DNA polymerase beta in vitro. Biochem. Biophys. Res. Commun. 140:666-673.
34. Paulus C, Nitzsche A, Nevels M. 2010. Chromatinisation of herpesvirus genomes. Rev. Med. Virol. 20:34-50.
35. Redon CE, et al. 2010. Histone H2AX and poly(ADP-ribose) as clinical pharmacodynamic biomarkers. Clin. Cancer Res. 16:4532-4542.
36. Roizman B, Knipe DM, Whitley RJ. 2007. Herpes simplex viruses, p 2501-2601. In Knipe DM, Howley PM (ed), Fields virology, 5th ed. Lippincott Williams and Wilkins, Philadelphia, PA.
37. Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, Poirier GG. 2010. PARP inhibition: PARP1 and beyond. Nat. Rev. Cancer. 10:293-301.
38. Satoh MS, Lindahl T. 1992. Role of poly(ADP-ribose) formation in DNA repair. Nature 356:356-358.
39. Showalter SD, Zweig M, Hampar B. 1981. Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4. Infect. Immun. 34:684-692.
40. Simbulan-Rosenthal CM, Rosenthal DS, Iyer S, Boulares AH, Smulson ME. 1998. Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose) polymerase in the early stages of apoptosis. J. Biol. Chem. 273:13703-13712.
41. Smith MC, Boutell C, Davido DJ. 2011. HSV-1 ICP0: paving the way for viral replication. Future Virol. 6:421-429.
42. Sodhi RK, Singh N, Jaggi AS. 2010. Poly(ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications. Vascul. Pharmacol. 53:77-87.
43. Stettler M, et al. 2006. New disposable tubes for rapid and precise biomass assessment for suspension cultures of mammalian cells. Biotechnol. Bioeng. 95:1228-1233.
44. Vastag L, Koyuncu E, Grady SL, Shenk TE, Rabinowitz JD. 2011. Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism. PLoS Pathog. 7:e1002124. doi:10.1371/journal.ppat.1002124.
45. Wang Y, et al. 2011. Poly(ADP-Ribose) (PAR) binding to apoptosisinducing factor is critical for PAR polymerase-1-dependent cell death (Parthanatos). Sci. Signal. 4:ra20. doi:10.1126/scisignal.2000902.
46. Weitzman M, Weller S. 2011. Interactions between HSV-1 and the DNA damage response. In Weller S (ed), Alphaherpesviruses. Caister Academic Press, Norfolk, VA.
47. Whatcott CJ, Meyer-Ficca ML, Meyer RG, Jacobson MK. 2009. A specific isoform of poly(ADP-ribose) glycohydrolase is targeted to the mitochondrial matrix by a N-terminal mitochondrial targeting sequence. Exp. Cell Res. 315:3477-3485.
48. Ying W, Sevigny MB, Chen Y, Swanson RA. 2001. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death. Proc. Natl. Acad. Sci. U. S. A. 98:12227-12232.
49. Yuan J, Bennett BD, Rabinowitz JD. 2008. Kinetic flux profiling for quantitation of cellular metabolic fluxes. Nat. Protoc. 3:1328-1340.
50. Zhou Y, Feng X, Koh DW. 2011. Activation of cell death mediated by apoptosis-inducing factor due to the absence of poly(ADP-ribose) glycohydrolase. Biochemistry 50:2850-2859.